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 Neonicotinoids are currently the most widely used insecticides in the world to treat crops 
and seeds in the commercial agricultural industry. Acting as nicotine analogues neonicotinoids 
signal to α-bungarotoxin (α-BT) sensitive insect nicotinic acetylcholine receptors (nAChR), 
which are expressed throughout the insect nervous system. The predominant nAChR in the 
mammalian brain is the α4β2 subunit that is resistant to α-BT but the α7nAChR, which is 
expressed at much lower levels and has been characterized on immune cells, is α-BT sensitive. 
Activation of nAChRs can initiate the cholinergic anti-inflammatory pathway (CAP) that has 
immunosuppressive capabilities. Cultures of porcine bone marrow derived dendritic cells 
(BMDC) stained with α-BT indicated that CD172a+SLA DR+ dendritic cells expressed the 
α7nAChR. We hypothesized that exposure to a 5 mg/kg body weight/day diet of the 
neonicotinoid imidacloprid (IMI) would activate the α7nAChR and the CAP causing suppression 
of virus-specific immunity to porcine reproductive and respiratory syndrome virus (PRRSV). 
Over the course of 14 days blood samples were collected and analyzed by flow cytometry, qRT-
PCR, and ELISA for cell populations, cytokines, humoral response, α7nAChR expression, and 
viral RNA. Hypothermia and reductions in body weight were observed in both PRRSV infected 
and uninfected groups receiving dietary supplementation with IMI. Serum cytokine production 
of IL-10 was increased in those groups receiving dietary IMI supplementation over the course of 
the experiment. Furthermore, CD172a+SLA DR+SSClo monocytes had reduced expression of 
major histocompatibility complex (MHC) class II (SLA DR) in infected piglets receiving IMI. 
Finally, elevated levels of virus-specific antibodies were measured at day 14 post infection (p.i.) 
in IMI treated groups. Infection with PRRSV increased production of virus-specific antibodies, 




Additionally, the ability for T-cells (CD3+) to produce interferon (IFN)-γ was increased at day 7 
p.i. compared to day 3 p.i. as a result of infection and regardless of dietary IMI supplementation. 
This is the first study, to our knowledge, to characterize the effects of neonicotinoids on the 
immune response to a viral pathogen in pigs. Our data indicates that IMI may adversely affect 
the generation of Type I immunity and increase virus-specific antibody production and promote 
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Neonicotinoids, a relatively new class of insecticides, are nicotine analogs and thus insect 
nicotinic acetylcholine receptor (nAChR) agonists. Neonicotinoids are widely used on feed 
crops, are present in water sources, and when ingested are absorbed in the intestine and 
disseminated to other organs [1-3]. In the US alone, it is estimated that 900 tons of clothianidin 
(CL) and 890 tons of imidacloprid (IMI) are applied to crops annually while almost all corn 
seeds in the U.S. are preemptively coated with neonicotinoids prior to planting [4]. Not only are 
neonicotinoids widely used but as little as one month after planting, puddles in corn fields were 
shown to contain up to 2.3 ug/L of CL [5]. Streams located in corn and soybean producing 
regions of the US contained concentrations as high as 0.5ug/L [6], and in Canada as much as 3.1 
ug/L CL [7]. This is significant because the target water level set by the EPA is 1.05 ug/L [8]. 
The DT50 of certain neonicotinoids, such as IMI and CL, can range from 200->1000 days in soil 
[9] the continued use of neonicotinoids as a seed coating agent would be expected to continually 
increase residues in ground water. Finally, data also suggest that neonicotinoids are detectable in 
food [10]. Of relevance, corn kernels at harvest contain IMI at concentration at or below 1 ug/kg 
per kernel [11] and could be detected in cereals post processing [12]. Because swine in the US 
are maintained on a diet primarily consisting of corn and soybeans, the above data indicates that 
pigs are ingesting feed containing residual neonicotinoids, the implications of which are not yet 
known. Due to their presumed specificity for insect nAChRs, the potential toxic effects of 
neonicotinoids on other species have not been extensively researched. One recent study using rat 
brain slice culture has provided data that demonstrates the ability for the neonicotinoids IMI and 
acetamiprid to activate α-bungarotoxin (α-BT) sensitive mammalian specific nAChRs [13]. The 




potential for activation of the cholinergic anti-inflammatory pathway (CAP) which results in 
immunosuppressive effects. 
Cholinergic Anti-Inflammatory Pathway 
The central nervous system (CNS) is an intricate network composed of sensory and 
motor neurons. Comprised of the brain and spinal cord, the CNS is responsible for processing 
information that is received from peripheral nerves. The immune system was previously 
identified as the source of cytokine production with the CNS under its control. However, now we 
recognize that there is bi-directional communication between the neuroendocrine and immune 
system [14]. Interleukin (IL)-1 mRNA, protein, and receptors in the brain and pituitary gland are 
prime examples of cytokines that serve a neuroendocrine function as they can promote fever 
development and the release of adrenocorticotropic hormone [14]. Communication between the 
brain and the immune system is required to efficiently resolve inflammatory responses. At least 
two feedback loops fulfill this demand, the hypothalamic-pituitary-adrenal axis (HPA) and the 
cholinergic anti-inflammatory pathway (CAP). The immunosuppressive capability of the CAP is 
demonstrated by the fact that experimental manipulation of the pathway greatly influences 
cytokine production which affects the severity of shock and inflammation induced by tissue 
injury [15]. The vagus nerve serves as the sensory arm of the inflammatory reflex where 
inflammatory signals can activate a motor response via efferent nerve fibers that will then 
suppress cytokine production in order to limit or prevent damage [16]. Initial studies showed that 
vagal nerve signaling can inhibit pro-inflammatory cytokines that exacerbate diseases such as 





The activation of the CAP begins with efferent neuron depolarization which results in the 
post-synaptic secretion of acetylcholine (ACh) in the liver and intestine [16]. Alternatively, 
depolarization of the splenic nerve causes the release of norepinephrine (NE). The NE signals to 
the β2-andrenergic receptors (β2AR) located on a subset of T-cells stimulating the release of 
ACh [19]. It is the release of ACh that will, in turn, activate the α7nAChR on macrophages and 
dendritic cells leading to the activation of the JAK2/STAT3 pathway and ultimately inhibition of 
NF-κB signaling (Fig. 1). Activation of the NF-κB pathway is paramount in the production of 
pro-inflammatory cytokines and inactivation will ablate the secretion of cytokines such as tumor 
necrosis factor (TNF)-α, IL-1β, IL-6, and IL-8 [20]. 
Nicotinic acetylcholine receptors (nAChRs) are part of a receptor family that consist of 
ligand gated ion channels that bind acetylcholine and nicotine [21]. As, explained previously 
AChRs are ligand gated ion channels that are constitutively expressed in the CNS, muscle tissue, 
and the immune system. Upon binding ACh or nicotine nAChRs  will undergo a conformation 
change that results in the rapid influx of cations such as Na+, Ca+2 which, in turn, culminates in 
the activation of signal transduction pathways or in the case of neurons, cell membrane 
depolarization and action potential generation [22]. These receptors play an important role in 
mediating cholinergic excitatory neurotransmission and neurotransmitter release [23]. There are 
two main categories of nAChR: homopentameric (α7, α8, α9) or heteropentameric ((α1)2β1γ𝛿, 
(α3)2(β4)3, (α4)2(β2)3, ect.) forms [22-24]. Since nAChRs are present on immune cells they 
likely play a role in lymphocyte development and immune responses [25, 26]. Indeed, nicotine 
acts to suppress pro-inflammatory responses that occur during viral infection or in models of 
autoimmunity and does so in a manner that is contingent on the activation of α7nAChR [23, 27]. 




cell maturation and activation [23, 25]. Additional research indicates these receptors affect 
lymphocyte development and survival of B-cells [28]. In fact, previous studies have shown α-BT 
sensitive nAChRs are also found on blood-borne macrophages and, through vagal nerve 
activation, inhibit the release of TNF and attenuate systemic inflammatory responses [29]. The 
α7nAChR is of particular interest since it is one of the best characterized of the nAChR, is α-BT 
sensitive, and thus may be a target of neonicotinoids. Previous studies have shown that mice 
deficient in the α7nAChR have exaggerated TNF levels following exposure to an endotoxin and 
α7nAChR null mice fail to suppress TNF cytokine synthesis [29]. A unique characteristic of the 
α7nAChR is its sensitivity to α-BT, a venom component of the Taiwanese banded krait 
(Bungarus multicinctus). The α4β2 nAChR, another predominant nAChR in the mammalian 
brain, does not show the same affinity for α-BT that is observed in insect nAChRs. Interestingly, 
like nicotine, neonicotinoids excerpt their toxicity to insects in a manner that is dependent on the 
constitutive activation of α-BT sensitive nAChRs. These receptors are highly expressed 
throughout the insect nervous system and activation results in energy store depletion and death 
from rapid cation influx. However, the activation of insect nAChRs by neonicotinoids are orders 
of magnitude greater than that of nicotine [30]. The low affinity of neonicotinoids for the α4β2 
nAChR, in part, explains their reduced neurotoxic potential in mammals [30, 31]. Nevertheless, 
recent studies have shown that both IMI and acetamiprid were capable of inducing Ca+2 influx in 
rat cerebellar slice cultures at low concentrations and was dependent on the activation of the α-
BT sensitive α7nAChR [13]. 
Immune Responsiveness 
 When an organism is exposed to a toxic or allergenic substance the immune system will 
become activated and utilizes both innate and adaptive mechanisms to detect and eliminate the 




contact with the first line of defense for the immune system: the innate immune response. 
Components of innate immunity includes soluble proteins and bioactive small molecules such as 
complement proteins, defensins, and ficolins that are constitutively present or released from cells 
once they are activated such as cytokines and chemokines. Other components of the innate 
immune system are membrane bound receptors and cytoplasmic proteins that recognize 
conserved molecular patterns present on invading pathogens or danger signals, these receptors 
are termed pattern recognition receptors (PRR) [32]. Cellular components that elicit effector 
responses of innate immunity include natural killer (NK) cells, monocytes/macrophages, and 
granulocytes.  
Neutrophils, basophils, eosinophils, and mast cells are different granulocytes 
differentiated from myeloid stem cells that function during the innate immune response assisting 
in pathogen clearance. Eosinophils are present when combating parasites and helminths infection 
while basophils typically appear in inflammatory reactions. Their rapid trafficking to sites of 
injury/infection and the release of granules triggers inflammation and edema as well. Both 
eosinophils and basophils are associated with allergy symptoms and asthma [33]. In addition, 
mast cells also make a significant contribution to the pathogen defense immune functions as well 
as their significant role in allergic responses, wound healing, and immune tolerance. Activation 
of PRRs on mast cells causes them to rapidly release and secrete their granules containing 
histamine which attracts other immune cells to the site of infection [34]. The mast cells can be 
detrimental due to their high affinity for binding immunoglobulin (Ig)E, which bind allergens 
resulting in massive granule release of histamines and cytokines that result in the typical allergy 
symptoms [33]. Interestingly, mast cells reportedly express major histocompatibility complex 




are the most abundant granulocyte and are responsible for producing large quantities of reactive 
oxygen species that are cytotoxic to bacterial pathogens. Neutrophils also produce enzymes that 
are important for tissue remodeling and repair after an injury [33]. The neutrophils are one of the 
first cells that will traffic to a site of trauma and are a marker for acute inflammation [35]. Even 
though these cells are short lived, typically not surviving for longer than a few days, they play an 
important role in pathogen clearance and produce TNF and IL-12 that are important in 
facilitating macrophage and NK cell activation [33, 36].  
 Monocytes/macrophages are differentiated from common myeloid progenitor cells and 
are highly phagocytic for both pathogens and particles that have been marked for clearance 
through the binding of Ig, complement, acute phase proteins, and other opsonins [33]. Monocyte 
trafficking to sites of chronic inflammation and infection occurs rapidly after initial infection and 
once at the site they will differentiate further into macrophages [37]. Tissue-infiltrated 
macrophages can persist for several months at sites of chronic inflammation and infection [33]. 
Nitric oxide production by macrophages is essential for the killing of microbial pathogens the 
macrophage simultaneously plays a regulatory role in the adaptive immune response by 
producing IL-12, IL-6, IL-1β, TNF, and causing vasodilation [33, 38, 39]. An interesting 
characteristic of macrophages is that they adopt different phenotypes depending on which 
activating signals are present when they differentiate from immature precursor cells [33]. The 
different phenotypes include classically activated macrophages, activated by interferon (IFN)-γ, 
which will produce high levels of IL-12 inducing inflammation. Alternatively activated 
macrophages are induced by IL-4, IL-10, or IL-13 and will produce IL-10, an anti-inflammatory 
cytokine [33, 40]. Another important function of macrophages is to serve as antigen presenting 




will present antigen peptides to different T-cell subsets. MHC class I molecules present peptides 
fragment to cytotoxic T-cells while MHC class II will present peptides to helper T-cells. The 
antigen presentation process is initiated when the toll like receptors (TLR) expressed on the 
macrophage cells comes in contact with a pathogen-associated molecular pattern (PAMP). 
Different pathogens are recognized by different TLRs: TLR2- gram positive bacteria, TLR3- 
endosomal double stranded RNA, TLR4- gram negative bacteria, TLR7- endosomal single 
stranded RNA viruses, ect. [40, 41]. When IFN-γ activates macrophages to upregulate their 
expression of surface MHC class II and the costimulatory molecules they can begin the process 
of taking up antigen and presenting it to helper T-cells [33].  
NK cells are differentiated from common lymphoid progenitor cells and are classified as 
large granular lymphocytes. The primary function of NK cells is to lyse target cells without 
requiring prior sensitization [33]. As such they play a role similar to that of the cytotoxic T-cell 
in the adaptive immune system. NK cells respond to the site of infection rapidly and once a cell 
is targeted for destruction NK cells release perforin to create channels in the cellular membrane 
and cause cell lysis or induce apoptosis by fas ligand [42]. Whereas other immune cells would 
recognize non-self cells through the MHC NK cells rely on a complex collection of activation 
and inhibitory cell surface receptors in order to recognize virus-infected or tumor cells [42]. NK 
cells can also become activated by certain cytokines that are secreted after PRR stimulation. 
Cytokines such as IL-12 and IFNs, produced by macrophages, will activate the cytotoxic 
properties of NK cells and stimulate them to produce IFN-γ [33]. Additionally, IL-12 stimulates 
differentiation of T helper cells toward a Th1 profile that will also release IFN-γ, IL-12, and TNF 
[43]. The production of these cytokines contributes to macrophage activation and cell-mediated 




 Notably the innate immune response induces and shapes the generation of the adaptive 
immune response. The cytokines and other components released by the innate immune system 
contribute to the activation of T- and B-lymphocytes [33]. Both are derived from the common 
lymphoid progenitor cells and have antigen-specific receptors that undergo somatic 
rearrangement of germ-line gene elements to form the T cell (TCR) and B-cell receptor (BCR) 
[33, 44]. This process of rearrangement allows the possibility for millions of different antigen 
receptors that will have unique antigen specificity [44, 45]. The antigen-specific receptors that 
are generated as a result of the adaptive immune response will then be able to amplify and target 
the infection or pathogen with specificity. 
 T-cells are an important line of defense if the innate immune system fails to clear an 
infection through the identification and destruction of infected cells. This process occurs by 
identifying if a cell is recognized as ‘self’ or not. After activation APCs such as macrophages 
and dendritic cells phagocytize pathogens and will present the MHC bound peptide fragment to 
T-cells. In order to become activated the TCR must first recognize the MHC that is presenting 
the peptide then CD28 needs to be activated by the co-stimulatory receptors CD80/CD86 [33]. 
The two step process is important in order to prevent T-cells from recognizing self antigen as 
foreign and T-cells will not become activated unless they have bound both sites [46]. The co-
stimulatory molecules are very important because full activation cannot occur in their absence. 
The different classes of MHC molecules are specific for different classifications of T-cells, MHC 
class I will only bind with CD8 on cytotoxic T-cells (CD3+CD8+) and MHC class II interacts 
with CD4 on helper T-cells (CD3+CD4+). The primary role for the cytotoxic T-cell is to identify 
and destroy virus infected cells and regulate immune responses [47]. Meanwhile, helper T-cells 




macrophages and cytotoxic T-cells as well as playing a role in the maturation process of B-cells. 
These helper T-cells can differentiate into a wide variety of subtypes (TH1, Treg, TH2, TH17, TH9, 
and TFH) each capable of secreting a different cytokine profile that facilitates different immune 
cell responses that are each tailored toward clearance of specific types of pathogens or promoting 
immunoregulation [33, 47]. Most notable is the TH1-type which produce IL-2 and IFN-γ and 
support cell mediated immune responses [48].  
  Finally, B-cells also generate antigen-receptors that exquisitely recognize pathogens [33]. 
Unlike the TCR the BCR can be secreted as antibodies by differentiated plasma cells. B-cells are 
responsible for the humoral immune response and secrete antibodies that are antigen specific. 
The antibodies that are produced by B-cells during infection will serve a variety of functions 
including neutralization, agglutination, precipitation, and complement activation all of which 
serve to block the attack of pathogens and/or target them for destruction by other cells of the 
immune system [33, 49]. Importantly, B-cells are also APCs that signal to helper T-cells through 
MHC class II dependent presentation of antigen. Recent studies, have proposed that antigen 
presentation by B-cells plays a role in the optimal priming of T-cells as well as the induction of 
T-cell tolerance or the failure to mount an immune response [44]. The ability of B-cells to 
activate and restrict T-cells responses is essential for the initiation of a strong specific antibody 
response and the prevention of non-specific humoral immunity [44]. MHC class II expression 
occurs very early in B-cell development at the progenitor cell stage. Like the T-cell, B-cells also 
possess co-receptors, CD19, CD81, and CD21 that assist in and enhance the activation process 
[49]. As was stated previously, helper T-cells assist in the maturation process of B-cells through 
the induction of isotype switching, where cytokines delineate the isotype of Ig produced and the 




inflammatory cytokine. IL-17 will stimulate B-cell recruitment via CXCL13 chemokine 
signaling as well as activation and initiation of a humoral response [50, 51]. In response to T-
dependent antigens B-cells will differentiate into memory cells or plasma cells that secrete high-
affinity antigen-specific antibodies [49]. T- and B-cell memory is crucial for the development of 
high affinity antibodies that can be rapidly produced following a secondary antigen challenge. 
This crucial process is a major factor in the long term protection against pathogens and the 
reason vaccinations are successful [33, 49].  
Prevalence & Usage of Neonicotinoids  
 Introduced in the late 1990’s IMI was the first neonicotinoid produced and is currently 
registered for over 140 crop uses in more than 120 countries making it by far the most commonly 
used insecticide in the world [52]. As of 2010 neonicotinoids made up 27% of the insecticide 
market [53]. Of all the neonicotinoids IMI was the world’s largest selling insecticide and second 
largest selling pesticide [4]. Subsequently, the neonicotinoids CL, thiamethoxam, thiacloprid, 
acetamiprid, nitenpyram, and dinotefuran were introduced into the agricultural market as 
effective insecticides and, in terms of market share, rival IMI [4]. Another factor promoting the 
use of this class of insecticide is its selective toxicity to insects over vertebrates as illustrated by 
their selectivity for the insect nAChRs [4, 54, 55].The wide-spread use of neonicotinoids as 
insecticides gives credence to their effectiveness which is undoubtedly attributable to their 
environmental stability, water solubility, as well as their ability to be rapidly absorbed through 
roots, foliage, pollen, and fruit and disseminated throughout the entire plant anatomy [4, 6, 9, 11, 
12, 54]. Certain varieties, like IMI, have a low soil persistence and high insecticidal activity at 
low application rates [56]. In fact, the efficiency by which the neonicotinoids IMI and CL are 
systemically disseminated enables seed coating (i.e. IMI; 1 mg/seed) as an effective treatment 




treated with neonicotinoids as seeds and, at present, it is not uncommon for untreated seeds to be 
unavailable for purchase [4]. Specifically, in North America several of the most popular 
commercially grown crops, such as corn, have no un-treated seed options available for large 
scale producers [4]. Aside from seed application foliar spray, trunk injection, and drip-irrigation 
are also an effective means of treating agricultural crops with neonicotinoids but the majority 
(60%) of treatments are administered through seed or soil applications [4, 52, 57]. Though 
poorly effective as contact insecticides the systemic protection provided by neonicotinoid 
treatment not only ensures protection against herbivorous insects, it has also been shown to 
protect plants against the transfer of vector born viruses [4]. As a result, neonicotinoids are 
currently recognized as the most effective insecticides available on the market. In addition to 
their use by crop farmers neonicotinoids have been utilized in other fields as well, these include 
basic pest control for homes, veterinary applications (flea, tick, ect. protection), and fish farming 
(rice water weevil control) [4, 58]. Other studies have shown that IMI and CL can exert sub-
lethal effects that include genotoxic and cytotoxic effects, ranging from impaired immune 
function, to reduced growth, and reproductive success, often below lethal doses [59].  
Neonicotinoids in the Environment 
 Several characteristics of neonicotinoid use are sources of concern when it comes to 
exposure to untargeted flora and fauna in the environment. For starters, the water solubility and 
DT50 of neonicotinoids has also been a source of environmental contamination. Since their 
introduction neonicotinoids have been observed in a variety of surface waters and an assessment 
of US streams was able to detect at least one neonicotinoid in 53% of the samples [3]. California 
alone had 89% contamination in surface water samples taken from agricultural regions of which 
19% exceeded the 1.05 μg/L chronic invertebrate Aquatic Life Benchmark value established by 




detectable levels of neonicotinoids present at an average level of 0.0518 µg/L and 0.0014-0.1657 
µg/L [60, 61]. A reason behind these levels of water contamination are that neonicotinoids can 
persist for extended periods of time in soil and repeated treatments result in further 
accumulation. In areas that have been routinely seed-treated annually with neonicotinoids over 
several years soil samples had levels of IMI between 18-60 μg/kg [59, 62]. Another analysis on 
edge-of-field surface runoff and tile drain water samples showed nearly 100% detection levels 
over a two year period in fields treated with thiamethoxam and CL of which several 
measurements exceeded governmental thresholds values [63]. Contamination from atmospheric 
deposition, surface runoff, tile drain discharge, and groundwater seepage losses are all 
contributing factors to the detectable levels being measured in wastewater [63, 64]. Build-up of 
neonicotinoids in water is not only damaging to the aquatic populations but also impacts 
individuals, plants, and wildlife downstream of the contamination source. As water treatment 
plants fail to clear neonicotinoids from water sources residual concentrations may increase [3]. 
Additionally, the systemic properties of neonicotinoids ensure that the treatments cannot 
be simply washed off prior to ingestion. Previous studies of produce collected from supermarkets 
in Lucknow, India showed that neonicotinoids were detectable in a variety of fruits (0.02-0.78 
mg/kg), vegetables (0.08-0.93 mg/kg), and grain cereals (0.01-0.1 mg/kg). Based on the values 
being seen in the environment authors were able to estimate the daily intake of neonicotinoids 
per person was between 4-131 ng/kg body weights [12]. A similar study conducted in Boston, 
MA determined that levels of neonicotinoids in fruits and vegetables ranges between 0.1-100.7 
ng/g and 0.1-13.2 ng/g respectively [10]. Additionally, honey samples collected from urban and 
suburban areas had levels of IMI and CL present (0.1-0.3 ng/g). Similar levels could also be 




neonicotinoids present (0.1-1.3 ng/g) [10]. Based on this information it is not surprising that 
studies have found a combination of neonicotinoids levels are present in the blood and urine of 
individuals at levels as high as 0.54 ng/ml when near sites that had recently been treated [65]. 
Neonicotinoid levels were still detectable in individuals that were not near sites of treatment 
indicating they were exposed through their daily life [65]. One study from Japan demonstrated 
that children as young as three had levels of total neonicotinoids present in their urine where 
concentrations ranged from 4.7-370.2 nM/g creatinine. From the same study researchers were 
also able to identify that the urine levels were increased during the summer months when most 
crop treatments took place [66]. Moreover, excretion kinetic analysis studies predicted a daily 
intake of 0.53-3.66 µg/day based on the analysis of acetamiprid, dinotefuran, CL, and IMI [65]. 
Lastly, different metabolites occur in plants that are being harvested for human and animal 
consumption which maintain a toxicity comparable to the parent compounds [4, 67]. Some of 
these metabolites have also been found to be carcinogenic in mice [55, 68, 69] but metabolites 
have also been observed in dogs and hens [67]. There is also a potential health risk for predatory 
animals that can develop accumulation toxicity due to eating large numbers of contaminated 
prey. While the toxicity is not necessarily fatal it can have other ramifications which include, but 
are not limited to, effects on reproductive capabilities, weight loss, and anorexia [59]. 
Effects of PRRSV on the Swine Industry 
Porcine reproductive and respiratory syndrome virus (PRRSV) infection is estimated to 
incur $600 million in annual losses [70]. The inclusion of infection with swine influenza virus 
and porcine epidemic diarrhea virus (PEDV) would more than surpass $1 billion. Notably this 
estimate does not include the economic impact of either DNA viruses or pathogenic bacteria. As 




responsiveness to infection and decrease mortality, even if by a fraction, is of high economic 
importance. 
PRRSV is a member of the family Arteriviridae, genus Arterivirus, and order Nidovirales 
characterized as small enveloped, linear, single-stranded positive-sense RNA viruses. Other viral 
vectors of this family include equine arteritis virus, lactate dehydrogenase-elevating virus, simian 
hemorrhagic fever, and wobbly possum disease virus [71]. Having first appeared in the late 
1980’s PRRSV spread to both Europe (Type I) and North America (Type II) where it had a 
dramatic and immediate effect on the swine industry. To this day, infection by PRRSV continues 
to be the most economically devastating disease of swine due to high mortality rates, ease of 
transmission, and lack of preventative control measures [70, 72]. Symptoms of PRRSV include 
respiratory distress and pneumonia in post weaning pigs, reduction in growth rate, increased 
mortality among all age groups, and high levels of reproductive failure amongst pregnant sows 
[73, 74]. After establishing an upper respiratory infection, alveolar macrophages and dendritic 
cells are the main sites for viral replication and can induce prolonged viremia and persistent 
infection that will last for months after the initial exposure [73, 75]. In response to infection, pigs 
mount a strong humoral response that is notorious for its inability to efficiently neutralize 
infectious particles due to a lack of neutralizing antibodies [76]. Overall, the adaptive immune 
response to PRRSV is deficient and the low levels of components of the adaptive immune 
response are insufficient to clear the viral infection [77-79].  Currently, PRRSV is identified as 
an endemic virus in those areas of the world that are major swine-producing regions. Previous 
studies that have analyzed the costs of a PRRSV infection at several different levels of swine 
production: breeding-farrowing phase $74.16/litter, nursery production $6.01/pig, grower-




costs of PRRSV can also be broken down into several categories such as veterinary costs 
increase 2-50% and labor costs increase 0-100%, the reduction in feed consumption requires a 
higher feed conversion ratio (FCR) 3-8%, and mortality rates can be 0-30% all of which are 
dependent on the age of pigs at the time of infection [80]. The current options for dealing with 
PRRSV include eradication and vaccination. Attempts to control PRRSV through systematic 
eradication have yet to be successful as a result of the viruses’ high transmissibility, 
heterogeneity, and persistence in infected animals [75, 81]. The cell culture attenuated virus 
vaccine has had little success in preventing PRRSV, it is unable to effectively clear the virus or 
prevent re-infection due to inefficient humoral, limited innate, and cell mediated immune 
responses [82]. Current research is also examining the efficiency of viral protection in gene-
edited pigs that are SIFLEC1 (CD169) null, a surface protein that serves as a viral receptor [83]. 
The results have been promising in that viremia and clinical signs were not detectable in 
SIFLEC1 null pigs. However, the study was analyzed with a single PRRSV isolate and the 
heterogeneity of PRRSV means that this method is not yet an effective form of viral control [83]. 
Hypothesis  
The present studies were aimed at characterizing the porcine expression of the α-BT 
sensitive α7nAChR on leukocytes and analyzing the effects of dietary supplementation with the 
neonicotinoid IMI on the innate and adaptive immune response following PRRSV infection. We 
hypothesized that exposure to the neonicotinoid IMI would activate the α7nAChR and the CAP 
causing suppression of virus-specific immunity. In order to test this hypothesis we infected 
neonatal piglets with PRRSV and maintained them on a diet consisting of 5mg/kg body 
weight/day of IMI. Over the course of 14 days blood samples were collected and analyzed for 
cell populations, cytokines, humoral response, and α7nAChR expression. Our data demonstrates 




also shows that dietary supplementation with IMI can result in physiological effects such as 
reduction in body weights and instances of hypothermia. Additionally, treatment with IMI may 
affect virus-specific antibody production, suppress the generation of IFN-γ producing T-cells, 
and increase viral dissemination in the spleen and promote viremia. Meanwhile infection with 
PRRSV increased the production of virus-specific antibodies, circulating monocytes, the percent 
of circulating cytotoxic T-cells (CD3+CD8+), and circulating IL-10. Finally, infection with 
PRRSV decreased levels of circulating helper T-cells (CD3+CD4+) and the expression of MHC 
class II. 
 
2. Materials and Methods 
Animal Husbandry 
Mice 
Eight to twelve week old male and female mice were used for these studies.  All mice 
were of the C57BL/6J strain and originally obtained from Jackson Laboratory (Bar Harbor, ME).  
Mice were housed under constant 12-h light/dark cycles and constant temperature in covered 
cages and fed with a standard rodent diet ad libitum. The experimental procedures described 
herein were approved by the Institutional Animal Care and Use Committee at the University of 
Illinois Urbana-Champaign and were performed in accordance with guidelines of the National 
Institutes of Health. 
 
Pigs 
Naturally farrowed male and female domestic Yorkshire piglets were obtained from the 
University of Illinois swine herd at postnatal day 2 or 3. Prior to arrival, all piglets received 1ml 




2/10 ml (100 mg/ml i.m.), and had their needle teeth clipped.  Upon intake to our animal facility 
piglets were injected with 1ml of Gentamicin (5 mg/ml i.m.) (Sparhawk laboratories Inc., 
Lenexa, KS). All experimental procedures described herein were approved by the Institutional 
Animal Care and Use Committee at the University of Illinois Urbana-Champaign and were 
performed in accordance with guidelines of the National Institutes of Health. 
Splenocyte Isolation 
Mice were anesthetized by intraperitoneal (i.p.) injection of ketamine (85-100 mg/kg) and 
xylazine (10-13 mg/kg) diluted in 0.1 ml of phosphate buffered saline (PBS; pH 7.4). After 
reaching a surgical plane of anesthesia spleens were collected for flow cytometry. In brief, 
spleens were broken apart with the plunger from a 3 ml syringe and passed through a 70 μm cell 
strainer (Corning, Corning NY). The strainer was washed with RPMI1640 media (UIUC cell 
media facility, Urbana, IL) supplemented with L-glutamine (1 mM) (sigma Aldritch, St. Louis, 
MO), sodium pyruvate (1 mM) (Sigma Aldritch, St. Louis, MO), 10% heat inactivated fetal 
bovine serum (FBS) (Corning, Corning, NY) and 1% penicillin/streptomycin (100 U each, 
Thermofisher, Carlsbad, CA) (R10S media). Cells were centrifuged at 300xg for 7 min., and 
pellets were lysed with 2 ml of red blood cell (RBC) lysis buffer (Biolegend; San Diego, CA) for 
1-2 min. at room temperature. The cells were washed with R10S and made into a single cell 
suspension in R10S before being counted using a hemocytometer. 
Flow Cytometry-Mouse 
The following antibodies were used for immunophenotyping of mouse splenocytes by 
flow cytometry: α-CD3-eFluor450 (clone: 17A2), α-CD4-AlexaFluor488 (clone: GK1.5) α-CD8-
PE (clone: 3B5), α-CD19-PE (clone: eBio1D3), α-CD11b-AlexaFluor488 (clone: M1/70), α-
CD11c-eFluor450 (clone: N418), α-Nk1.1-PE (clone: PK136), and α-CD49b-FITC (clone: DX5) 




CA) was used to examine α7nAChR expression. In brief, 5x105 cells were stained for 20 min. in 
PBS containing 2% FBS. Cells were then centrifuged at 300xg for 5 min. and washed using 
PBS+2% FBS solution. Immunophenotyping was determined using a LSRII Flow cytometer 
(BD, San Jose, CA).  Gates were determined using unstained and single stained samples.  Results 
were analyzed using FCS Express 6 Flow cytometry software (De Novo Software, Los Angeles, 
CA).  
Bone Marrow Derived Dendritic Cell Cultures 
Piglets between >1-4 weeks old were used to isolate bone marrow and generate bone 
marrow derived dendritic cells (BMDC) cultures. Piglets were euthanized and rear limbs were 
removed at the hip so the femur and tibia could be dissected inside a biological safety cabinet. 
Muscles were carefully removed from the bones with a scalpel and surgical scissors. After the 
bones were isolated they were dipped in ethanol before being secured with a mounted clamp and 
split lengthwise with an electric hand saw (Mopec, Oak Park, MI). Bone marrow was collected 
in PBS+2% FBS and centrifuged at 300xg for 5 min. following which the pellet was treated with 
RBC lysis buffer for 5 min. Cells were washed with D10S and passed through a 70 μm cell 
strainer (Corning, Corning NY) before being made into a single cell suspension in D10S. Cells 
were plated at 1x107 cells/plate in 100 mm petri dishes with recombinant porcine granulocyte-
macrophage colony-stimulating factor (GM-CSF) (20 ng/ml) and IL-4 (20 ng/ml). Both 
recombinant proteins were obtained from R&D systems (Minneapolis, MN). Cells were cultured 
at 37°C and 5.0% CO2 for 7-10 days with partial media changes every 3 days. 
In Vitro Imidacloprid Treatments 
Porcine BMDC were washed with PBS and removed from plastic ware by adding 5 ml of 
ice cold sterile Hanks buffered salt solution without calcium (HBSS, UIUC cell media facility, 




HBSS was pipetted up and down plate to remove cells which were then centrifuged at 
300xg for 5 min. The cells were washed and brought to a single cell suspension in D10S. Cells 
were plated at 5x105 in 96-well plates (Corning, Tewksbury, MA) with D10S and cultured at 
37°C and 5.0% CO2 overnight. The next day cells were pretreated with 500 μM IMI for 30 min 
followed by treatment with 10 ng/ml lipopolysaccharide (LPS, Sigma Aldritch, St. Louis, MO). 
After 24 hrs. media was collected and stored at -80°C while cells were fixed with 4% 
paraformaldehyde (PFA, Acros Organics, New Jersey, US).  
Immunohistochemistry 
Fixed porcine BMDC cultures were blocked in PBS with 5% goat serum (Sigma 
Aldritch, St. Louis, MO) and 0.3% Triton X-100 (Sigma Aldritch, St. Louis, MO) for 1 hr. 
Tissues were incubated with a rabbit α-Iba-1 (1:1000, Wako, Japan) and α-Bungarotoxin-
AlexaFluor647 (1:20, Thermofisher, Carlsbad, CA). Tissues were washed three times for 5 min 
using PBS and then stained using species specific secondary antibody (Alexa Fluor 488 goat α-
rabbit 1:1000 Life Technologies, Eugene). Nuclei were stained using Hoechst 33342 
trihydrochloride (1:4000 Life Technologies, Carlsbad, CA) for 1 min in PBS. Cells were imaged 
using a Cytation 5 image reader (BioTek, Winooski, VT) using Gen5 software and quantitated 
with Image J. 
Experimental Design for Dietary Imidacloprid Treatment and PRRSV Infection 
 Piglets were weight matched into one of four possible treatments in a 2 by 2 factorial 
arrangement, IMI supplementation and PRRSV infection.  Piglets were allowed 5 days of 
acclimation to their new environment prior to experimentation.  All piglets were housed in 
ABSL2 containment, with PRRSVs inoculated piglets housed separately from saline inoculated 
controls in order to avoid cross-contamination. All piglets were housed individually to control 




Manufacturing; Colorado Springs, CO) to help maintain appropriate local temperatures as well 
as a toy for environmental enrichment (plastic Jingle Ball™, Bio-Serv, Frenchtown, NJ). The 
cage flooring consisted of vinyl-coated metal (Tenderfoot/NSR, Tandem Products, Inc., 
Minneapolis, MN) and allowed urine and feces to fall through the flooring. Piglets were limit fed 
a Liqui-wean milk replacer diet (Milk Specialties; Eden Prairie, MN) that was reconstituted daily 
to a final concentration of 206 g/L using tap water and supplied at a rate of 285 ml/kg/day 
delivered to a stainless steel bowl from a reservoir via a peristaltic pump (Control Company, 
Friendswood, TX). Using this automated feeding system (similar to previously described [84]) 
piglets received their daily allotted milk over the course of 14 meals (one per hour from 0600 hr. 
to 2400 hr.).Data were generated from two individual experiments. 
Dietary Imidacloprid Treatment 
Piglets in the treatment group received a diet supplemented with IMI (5mg/kg body 
weight/day; 95% purity, BOC Sciences, Shirley, NY).  Each morning IMI was dissolved in 
dimethyl sulfoxide (DMSO) and diluted 1/1000 in milk replacer.  Pigs in the non-treatment 
group received vehicle (DMSO) diluted in their milk replacer.  Dietary treatments for both 
groups began the day prior to infection and lasted the duration of the study. 
Observation 
Weights, rectal temperatures, feeding scores, and sickness behaviors were recorded daily. 
Feeding scores were recorded to assess willingness of the piglets to consume their first daily 
meal using a scoring system (1 = no attempt to consume the milk; 2 = attempted to consume the 
milk, but did not finish within 1 min; 3 = consumed all of the milk within 1 min). Sickness 





The P129-BV strain of porcine reproductive respiratory syndrome virus (PRRSV) was 
obtained from Dr. Van Alstine and the School of Veterinary Medicine at Purdue University 
(West Lafayette, IN). Between postnatal days 5-7 piglets were inoculated with either 1 ml of 
sterile PBS or 1x105 TCID50 PRRSV dissolved in 1 ml sterile PBS. 
Tissue Collection 
Blood was collected on days 0, 3, 7, 14 and 25 post infection (p.i.) via jugular 
venipuncture into K2 EDTA plasma tubes and uncoated serum tubes (BD; Franklin Lakes, New 
Jersey, USA) . Serum was harvested by centrifugation at 2000xg for 15 min. Peripheral blood 
mononuclear cells (PBMCs) were isolated from K2 EDTA coated tubes by Ficoll (Sigma; St 
Louis, MO) gradient centrifugation. 
For euthanasia, piglets were anesthetized using a telazol:ketamine:xylazine drug cocktail 
[50 mg of tiletamine plus 50 mg of zolazepam reconstituted with 2.5 mL ketamine (100 g/L) and 
2.5 mL xylazine (100 g/L); Fort Dodge Animal Health, Fort Dodge, IA] administered i.m. at 
0.03 mL/kg body weight. Piglets were then euthanized via intracardiac injection of sodium 
pentobarbital (86 mg/kg body weight; Fatal Plus, Vortech Pharmaceuticals, Dearborn, MI). Lung 
and spleen biopsies were isolated during the dissection at either day 14 or 25 p.i. Single cell 
suspensions from cervical lymph nodes and spleen biopsies were prepared by passing tissues 
through 70 µm filters (Corning, Corning NY) into R10S. Single cell suspension from lungs were 
prepared by first mincing tissue biopsies with a sterile razor blade.  Tissue was then 
enzymatically digested with Acutase (Thermo Fisher; Carlsbad, CA) for 45 min at 37°C and 5% 
CO2 then passed through a 70 µm filter. Cells were centrifuged at 300xg for 5 min. and lysed 
with 3-5 ml of RBC lysis buffer for 2-3 min., then washed and re-suspend in R10S. Cells were 





The following antibodies were used for immunophenotyping of pig leukocytes by flow 
cytometry: α-CD3ε-PE (clone: BB23-8E6-8C8), α-CD3ε-PerCP-cy5.5 (clone: BB23-8E6-8C8), 
α-CD3ε-PerCP (clone: BB23-8E6-8C8), α-CD3ε-FITC (clone: BB23-8E6-8C8), α-CD4a-PE-cy7 
(clone: 74-12-4), α-CD8a-AlexaFluor647 (clone: 76-2-11), α-CD8a-PE (clone: 76-2-11), α-CD5-
FITC (clone: 1H6/8, BioRad; Hercules, CA), α-SLA Class II-FITC (clone: 2E9-13, antibodies 
online; Atlanta, GA), α-CD80-eFluor450 (clone: 16-10A1; ebioscience, San Diego, CA), α-
CD172a-PE (clone: 74-22-15A), α-IFN-γ-PerCp (clone: P2G10), α-IFN-γ-PE (clone: P2G10), 
and α-IFN-γ-PerCP-cy5.5 (clone: P2G10) (ebioscience, San Diego, CA). α-Bungarotoxin-
AlexFluor647 (Thermofisher, Carlsbad, CA) was used to assess expression of α7nAChR. 4,6-
Diamidino-2-phenylindole (DAPI), and fixable viability dye 780 (ebioscience, San Diego, CA) 
were used to assess viability. All reagents for flow cytometry were obtained from BD 
Biosciences (Franklin Lakes, New Jersey, USA) unless otherwise noted. Immunophenotyping 
was determined using a LSRII flow cytometer (BD, San Jose, CA). Gates were determined using 
unstained and single stained samples. Results were analyzed using FCS Express 6 flow 
cytometry software (De Novo Software, Los Angeles, CA). 
In brief, 5x105 cells were blocked with α-mouse CD16/CD32 (clone: 93) for 10 min then 
stained for 20 min (The first cohort of pigs were not blocked) suspended in PBS with 2% FBS. 
Cells were then centrifuged at 300xg for 5 min. and washed using PBS+2% FBS solution. 
Intracellular cytokine staining (ICS) was performed on 1x106 cells following four hours of 
treatment with Brefeldin A (BFA, ebioscience, San Diego, CA), recombinant porcine IL-12 (20 
ng/ml; R&D Systems Minneapolis, MN) and BFA, or PMA (50 ng/ml) (Sigma-Aldrich, St. 




cells were blocked with α-CD16/CD32 (clone: 93) in PBS+2% FBS for 10 min. then stained for 
20 min. Cells were then centrifuged at 300xg for 5 min. and fixed with fixation buffer 
(ebioscience, San Diego, CA) for 20 min. at 24°C.  After washing twice with 1 ml of 
permeabilization buffer (ebioscience, San Diego, CA) intracellular stains were applied to cells 
for 20 min. After staining, cells were washed with permeabilization buffer and re-suspended in 
PBS+2% FBS. Gates were determined using unstained and single stained samples resulting from 
the same tissue.  Results were analyzed using FCS Express 6 Flow cytometry software (De Novo 
Software, Los Angeles, CA). 
Cytokine Measurements 
 Serum and culture medium concentrations of IL-10 and TNF-α were determined by 
ELISAs according to manufacturer’s instructions (R&D Systems, Minneapolis, MN). 
Virus-Specific Antibody Levels 
 Serum PRRSV-specific antibody levels were determined by ELISA according to the 
specifications of IDEXX (Westbrook, ME). Serial dilutions of Day 14 samples were used to 
determine antibody titer. Plates were measured at 680 nm and OD values were recorded. 
Viral RNA Levels 
 Viral RNA in the lung, spleen, and plasma was estimated by real-time quantitative 
reverse transcription PCR (qRT-PCR).  In brief, total RNA was isolated from lung and spleen 
biopsies using Tri Reagent (Sigma Aldritch, St. Louis, MO) according to the manufacturer’s 
instructions. The RNA quality and purity was determined using a NanoDrop spectrophotometer 
ND-1000 (Thermofisher, Carlsbad, CA).  Total RNA was reverse transcribed to cDNA and 
amplified and semi-quantified using VETMAX™ NA and EU PRRSV Reagents specific primers 




thermocycler according to manufacturer’s instructions.  Results are reported as fold change in 
ΔCT.  
Statistical Analysis 
 Data were analyzed using Student’s T-tests, Mantel-Cox, and multi-level analysis of 
variance followed by Bonferroni post-hoc analysis. Statistical significance was set at p≤0.05. 
Data are reported as means ± standard error (S.E.). Analysis was performed using GraphPad 
Prism version 7.00 for Windows (GraphPad Software, La Jolla, CA) or SAS™ software. 
Quantity of animals used for the following experiments are shown in the figure legends. 
3. Results 
Expression pattern of α7nAChRs on immune cells 
 It has been shown that human and mouse immune cells express alpha-7-nicotinic 
acetylcholine receptors (α7nAChR) [23, 25, 85, 86], and that signaling to these receptors 
dampens immune responses [85, 87]. However, the expression profile of the porcine α7nAChR 
on immune cells has not, to our knowledge, been defined.  Therefore, we used fluorescently 
labeled α-BT, a neurotoxin that irreversibly and selectively binds α7nAChR, coupled with flow 
cytometry to determine the cellular expression on porcine immune cells.  
Mouse splenocytes were initially analyzed to determine which immune cells were likely 
to have the highest expression of the α7nAChR. Our mean fluorescent intensity (MFI) analysis 
of α-BT stained cells isolated from mouse splenocytes indicated that T-cells (CD3+), including 
helper T-cells (CD3+CD4+) and cytotoxic T-cells (CD3+CD8+), exhibited a low level of receptor 
expression (Fig. 2A). However, macrophage (CD19-CD11b+CD11c-) and B-cell (CD19+CD11b-) 
expressed high levels of the receptor on their surface (Fig. 2B-C). The last population analyzed 




(Fig. 2D). Together, our data verified that mice do express the α7nAChR and it is most highly 
expressed on the macrophage and B-cell populations. 
The MFI analysis of α-BT from porcine blood indicated that both cytotoxic (CD3+CD8+) 
and helper (CD3+CD4+) T-cell populations exhibit a low level of receptor expression (Fig. 3A).  
In contrast, NK (CD3-CD4-CD8+), monocytes (CD172a+SSClo), and granulocytes 
(CD172a+SSChi) exhibited a much higher level of surface binding with α-BT (Fig. 3B-D). 
Interestingly, the expression profile of the α7nAChR on immune cells was nearly identical to 
what we observed in mouse splenocytes (Fig. 2A-B, D). An exceptional difference was the 
higher levels of α-BT binding observed on porcine NK cells, a finding that is more consistent 
with what is seen in the human profile as has been reported previously [85].  Binding of α-BT on 
T-cell (CD3+) and monocyte (CD172a+) populations from the spleen were also examined (Fig. 
4A-B) as well as BMDC cultures. Analysis of cultured dendritic cells obtained from porcine 
bone marrow indicated that this cell population also exhibits α-BT sensitivity (Fig. 5A-B) and 
treatment with IMI caused an upregulation in MFI of α-BT surface staining (Fig. 6B).We 
observed similar low levels of expression on splenic T-cells but monocyte binding of α-BT was 
lower than those in the blood. Taken together, these data strongly indicate that the expression 
profile for the α7nAChR on immune cells is relatively conserved across species and that the 
receptor expression pattern in the pig is more similar to that of humans. 
Effects of Infection and Imidacloprid on Weights, Temperatures and Feeding Scores 
 Body weights, rectal temperatures, and feeding scores for each piglet were measured 
daily for the duration of the study and used as indices of sickness behavior. Interestingly, piglets 
that received dietary supplementation of IMI displayed a reduction in body weight compared 
with piglets that received dietary supplementation of vehicle (Fig. 7A). As observed previously 




lasting until day 14 p.i. (Fig. 7B).  Regardless of treatment, the onset of fever corresponded well 
with an observed reduction in feeding score (Fig. 7C). Ingestion of IMI also reduced rectal 
temperature, an effect that was most prominent during the first week (Fig. 7B).  However, 
feeding scores were unaffected by treatment with IMI (Fig. 7C). Together, these data indicate 
that PRRSV infection causes sickness behavior and also that dietary supplementation with IMI at 
5 mg/kg body weight/day is capable of noticeable changes in physiology.  
Dietary Imidacloprid Increased Serum IL-10 Levels 
 Determining if IMI treatment altered the production of serum cytokines was useful to 
identify immunosuppressive effects and a possible sign of cell activation. Serum samples were 
analyzed for IL-10 and TNF-α levels by ELISA over the course of the experiment. Interestingly, 
we found that at days 7 and 14 p.i. infected piglets showed higher serum levels of circulating IL-
10 (Fig. 8A). Dietary supplementation with IMI increased circulating IL-10 in both PRRSV 
infected and non-infected groups over the course of the experiment (Fig. 8A). However, no 
differences were seen in the concentrations of TNF-α being produced between groups (Fig. 8B). 
These data indicate that infection with PRRSV upregulates circulating IL-10. 
Effects of Imidacloprid and PRRSV on Circulating Leukocytes 
 Next, we questioned whether IMI treatment was capable of altering the percentages of 
circulating immune cells during the course of acute PRRSV infection.  Flow cytometric analysis 
of cells isolated from the blood at days 0, 3, 7, and 14 p.i. were used to determine the effects of 
infection and dietary IMI on leukocyte populations (Fig. 9A).  Infection with PRRSV increased 
circulating monocytes (CD172a+SSClo) at days 7 and 14 p.i. (Fig. 9B). In contrast, the 
percentage of granulocytes (CD172a+SSChi) was highest at day 3 p.i. but quickly returned to 




Furthermore, we found that infection reduced the percentage of surface MHC class II 
(SLA DR) on monocytes at days 3 and 7 p.i. (Fig. 9E).  Further analysis showed that at day 14 
p.i. the MHC class II surface expression on monocytes (CD172a+SSCloSLA DR+ ) was reduced 
the IMI treated PRRSV group (Fig. 9E). In order to determine if the decline in MHC class II+ 
cell percentages was the result of lower cell numbers or a decrease in surface expression per cell 
we analyzed the mean fluorescent intensity (MFI) of MHC class II on monocytes. Our results 
indicate that PRRSV infected piglets had a lower MFI over the course of the experiment but the 
cell counts remained the same between treatment groups indicating that the lower expression was 
a result of a decrease in the receptor expression per cell and not a decrease in cell numbers (Fig. 
9F). The percentage of MHC class II surface expression on granulocytes (CD172a+SSChiSLA 
DR+) was lower in PRRSV infected piglets at day 3 p.i. (Fig. 9E). The surface expression of 
CD80 on the monocyte and granulocyte populations were not different between groups (Fig. 
9D).   
Analysis of circulating lymphocyte populations indicated that infection reduced the 
percentage of circulating T-cells (CD3+) at day 7 p.i. (Fig. 10B).  Infection decreased circulating 
helper T-cells (CD3+CD4+) throughout the course of the experiment (Fig 10B).  In contrast, the 
percentage of cytotoxic T-cells (CD3+CD8+) were elevated in infected piglets at day 14 p.i. (Fig. 
10B). Infection did not affect the percentage of double positive T-cell populations (CD3+CD4+ 
CD8+) (Fig 10B) or the percentage of NK cell (CD3-CD8+) populations (Fig. 10C). The ability 
for T-cells to produce IFN-γ was analyzed by intracellular cytokine staining and flow cytometry 
(Fig. 10D). Infection increased the percentage CD3+IFN-γ+ cells at day 7 p.i. compared with day 
3 p.i. (Fig. 10E). Furthermore, treatment with IMI appeared to reduce the percentage of 




significance (Fig. 10E). Collectively, these data indicate that dietary IMI has little, if any, effect 
on the percentage and effector function of circulating leukocytes during PRRSV infection. 
The Effect of Dietary Imidacloprid on PRRSV-Specific Antibody Levels 
 In order to determine the ability for dietary IMI to affect humoral immunity we measured 
virus-specific antibodies levels in the plasma. We found that PRRSV infected piglets developed 
a small but detectible antibody response at day 7 p.i. This response was greatly increased at day 
14 p.i.  In contrast, virus-specific antibody was not detectable in non-infected piglets (Fig. 11A). 
Within infected groups, the antibody level was saturated at a dilution of 1/40 at day 14 p.i.  
Therefore, in order to better analyze antibody levels between the PRRSV infected group serial 
dilutions of plasma were analyzed (Fig. 11B). Our results indicate that piglets which received 
dietary supplementation of IMI had higher levels of circulating antibody than vehicle control 
piglets (Fig. 11B) which was also evident after measuring the antibody titer (Fig. 11C).  
Together, this indicates that dietary supplementation with IMI increased virus-specific antibody 
production at day 14 p.i. 
Effects of Dietary Imidacloprid on PRRSV Dissemination 
 Next, we questioned whether dietary IMI could alter the viral RNA levels in different 
tissues. Previous studies have identified the lung as the primary site of PRRSV replication, but 
virus can also be detected in lymphoid tissues including regional lymph nodes, thymus, and 
spleen [76, 88].  Therefore, lung, spleen, and plasma samples were collected for viral RNA 
determination by real-time qPCR. Our results show that viral RNA was highly expressed in lung 
biopsies obtained from infected piglets at day 14 p.i.  However, viral RNA levels of infected 
piglets were almost identical between treatment groups in the lung at this time-point (Fig. 12A).  




spleen (Fig. 12B), indicating that IMI may cause an increase in viremia and dissemination.  
Based on these data we next analyzed the effect IMI on viral RNA in the plasma of infected 
piglets at days 7 and 14 p.i. (Fig. 12C). No differences were detectable between vehicle and IMI 
groups at day 7 p.i.  However, at day 14 p.i. piglets supplemented with IMI appeared to have 
increased levels of viral RNA. Together, these data suggest that dietary supplementation with 
IMI may influence the viremia and pathogenesis of PRRSV. 
 
4. Discussion  
Findings 
 First, the expression profile of the α7nAChR on mouse cells was analyzed to verify that 
we could detect binding of α-BT by flow cytometry. Our initial analysis of mouse immune cells 
suggested that cells associated with innate immunity had the highest surface receptor expression 
which was similar to what we observed in pigs although with some population differences. Next, 
we used a porcine model to investigate the potential for dietary IMI supplementation to alter the 
generation of immune responses during infection with an upper-respiratory pathogen. We found 
that daily dietary supplementation with IMI caused bouts of hypothermia that were independent 
of infection status.  Treatment also reduced body weight, an effect that was most prominent in 
infected piglets.  Additionally, we showed that infection with PRRSV increased circulating 
levels of IL-10 while treatment with IMI caused slightly elevated levels over the course of the 
experiment. Finally, our data also indicates that IMI treatment during infection increased virus-
specific antibody production, and may also promote viremia and viral dissemination. To our 
knowledge this study is the first to investigate the effects of IMI on the generation of pathogen-




Activation of the Cholinergic Anti-inflammatory Pathway 
 The cholinergic anti-inflammatory pathway (CAP) has a crucial role in reducing 
inflammation [15, 89]. The α7nAChR is one of the principal components of the CAP [23, 27] 
and is required for transducing the immunosuppressive signal from the CNS. Our data confirms 
the presence of the α7nAChR on a variety of cell types in both mice and pigs. Previous studies 
have shown that humans express the α7nAChR on NK cells where it functions to suppress IFN-γ 
production and cell cytotoxicity [85]. Our results suggest that expression of the α7nAChR on pig 
leukocytes is more similar to what has been seen in human cells then what we observed in mice. 
However, we did find that both mice and pigs had very high receptor expression on 
macrophages/monocytes and dendritic cells with much less expression on T-cells.  
Previous studies have shown that treatment with nicotine attenuates pro-inflammatory 
responses through nAChR signaling. Activation of the α7nAChR was critical for this outcome 
[21, 23, 27].  Other experiments have also shown that the CAP will become activated in order to 
modulate a systemic inflammatory response during an endotoxin challenge [15, 89, 90]. In the 
current study, we observed an increase in the virus-specific antibody production to PRRSV at 
day 14 p.i. in the piglet group that received dietary supplementation with IMI. The increase of 
circulating IL-10 could play a role in the upregulation of PRRSV-specific antibodies. 
Additionally based on the cell populations that expressed the α7nAChR there could also be 
reduced efficacy of the antigen presenting cells that inhibits the ability to clear the virus. For 
example, IMI may act to inhibit phagocytosis or nitric oxide production on macrophage. Indeed, 
the activation of the CAP has been shown to attenuate CNS inflammation and alters the cytokine 
profile. Additionally, nicotine has been shown to have effects on a variety of different cell types 




the number of B cells (CD3-CD19+) in the spleen, DC (CD11c+), CD11b+ infiltrating monocytes, 
and microglial cells. The expression profiles of MHCII, CD80, and CD86 were also down 
regulated on NK, DC, and monocytes [23]. Activation of the α7nAChR on NK cells caused an 
increase in intracellular calcium, reduced NF-κB signaling, ablated IFN-γ production, and 
inhibited DC maturation [85]. The effect on cells crucial for the initiation of an immune response 
can then lead to a suppression of T cell differentiation as well as altering the cytokine profile of 
helper T-cells [23]. Given the similarities between humans and pigs which were observed here 
further studies should focus on the porcine model in order to understand how neonicotinoids 
such as IMI are affecting virus-specific responses. 
Imidacloprid Promotes PRRSV Infectivity 
 Previous studies have shown that levels of neonicotinoids are detectable in a variety of 
substances including fruits, vegetables, and cereals at levels between .01-.32 mg/kg [10-12]. 
Additionally, the pesticide can persist in the soil and water supplies surrounding treated areas [8, 
60, 61, 91, 92]. While the values being detected may be low the half-life (DT50) for IMI has been 
reported to be anywhere from 200->1000 days [9]. The DT50 that are in excess of one year 
suggest that neonicotinoid concentrations may accumulate especially given continuous 
applications [59, 62]. Also, toxicity tests performed in the honeybee show that chronic exposure 
of IMI and its metabolites have a toxicity that is 3,000–100,000 times higher than in an acute 
exposure [4, 93-96]. Meanwhile, in human studies acute exposure is often the result of patients 
who have ingested IMI where the average consumption was 15 mL, with an IMI plasma 
concentration of 10.58 ng/L, resulting in mild symptoms such as nausea, headache, and diarrhea.  
Two patients experienced more serious effects such as respiratory failure and unconsciousness 
[97]. Therefore, while it is unlikely exposure will occur at the 5 mg/kg body weight/day dose that 




level (NOAEL) for chronic exposure of 5.7 mg/kg/day assigned by the EPA. Studies which used 
doses that ranged from 10-90 mg/kg/day of IMI in rats resulted in reduced growth rates [98]. 
Even with a dose below the NOAEL we still were able to observe physiological changes such as 
hypothermia and diminished body weights. 
 Urinary metabolites and other biological markers, such as serum levels, allow for a direct 
and objective way to assess exposure.  Several studies have shown that neonicotinoids are 
detectable in human urine and blood samples [66, 99-103]. Samples of urine had median levels 
of IMI at .15 ng/ml and increased to .54 ng/ml for individuals that were near sites recently 
treated with IMI pesticides [101]. Even during acute exposure and toxicity, IMI is easily 
absorbed and extensively metabolized resulting in detectable amounts of IMI and its two major 
metabolites, 6-choloronicotinic acid (6-CAN) and 6-hydroxyicotinic acid (6-HNA), in blood, 
urine, feces, and organs [12]. Chronic exposure was also evaluated in urine metabolites of turf 
sprayers across an entire spraying season, as well as only during active spray periods at peak 
spraying season, the median IMI level found in urine was 0.13 µg across spraying season [104]. 
Furthermore, concentration levels in blood can be highly time dependent due to tissue clearance.  
Therefore, duration of time following exposure is an important aspect to consider when 
measuring levels of IMI and its metabolites [2]. At a minimum, these data demonstrate the 
ability for neonicotinoids to bind human nAChRs.  
Additionally, our data showed that circulating IL-10 production was increased following 
infection with PRRSV. Previous studies have shown an increase in circulating IL-10 following 
infection with PRRSV in vivo as well [105] . Other studies have also identified that the 
infectivity of PRRSV is positively correlated when non-neutralizing levels of PRRSV-specific 




order to enhance B-cell survival and antibody production [49]. The elevated levels of non-
neutralizing antibody aid in a process known as antibody dependent enhancement (ADE) that 
contributes to viral pathogenesis. Non-neutralizing antiviral antibodies assist in viral 
pathogenesis by facilitating viral entry into cells most notably through the Fcγ receptor [106, 
107]. This is significant because our results showed elevated levels of IL-10 as well as PRRSV-
specific antibodies in the PRRSV infected groups that received dietary supplementation with 
IMI. If exposure to IMI increases circulating IL-10 during infection with PRRSV there may be 
increased viral dissemination and viremia.  
Neonicotinoid Absorption & Behavioral Effects 
In order to identify the effects that neonicotinoids may have on physiology it is important 
to consider their site of absorption. Since detectable levels of neonicotinoids have been measured 
in commercially grown crops and water sources ingestion represents a key route of entry into the 
body. Therefore, the intestine is likely the main site for absorption as has been documented in 
human and animal subjects [1, 2]. The insecticides can be absorbed by passing through the 
transepithelial barrier with some neonicotinoids being absorbed with 100% efficiency as 
illustrated by studies utilizing human cell culture models [1, 108]. The efficient rate of 
absorption indicates that exposure to neonicotinoids through food could pose a significant health 
risk. Following absorption neonicotinoids may bind to the α7nAChR, which we have identified 
on a variety of porcine leukocytes, resulting in activation of the CAP. Comparisons between 
human and pigs [109] indicate that there is approximately 80% similarity in immunologically 
related genes. Importantly, the postnatal gut development and nutritional requirements of piglets 
closely resembles that of human infants as well [110, 111]. Other similarities have been noted 
between the CNS and brain of pigs and humans including the predominance of white matter, 




the effect of neonicotinoids in rats showed an anxiogenic effect from thiamethoxam 
administration as well as elevated anxiety-like behaviors during unpredictable chronic stressors 
following the administration of CL [113]. These data indicate that neonicotinoids are capable of 
effecting the mammalian brain even though they have poor penetration of the blood brain barrier 
(BBB) [31]. Based on this information not only are pigs likely to have absorption of 
neonicotinoids take place in the gastro intestinal tract and potentially result in behavioral changes 
but it is probable that any effects seen in pigs is similar to what would be seen in humans. 
Imidacloprid’s Effect on the Immune Response 
 Neonicotinoids became very popular due to their specificity to the insect nAChRs. By 
acting as nAChR agonists neonicotinoids activate voltage-gated calcium channels that results in 
the over stimulation of neurons which ultimately causes death in insects [54]. However, 
interaction with the receptor can vary based on the chemical and species being affected. The 
nAChR sensitivity to IMI can be modulated by intracellular phosphorylation mechanisms which 
result in desensitization [114]. Currently, the majority of studies on neonicotinoids have revolved 
around its effect on insects with the majority of research focused on the role it’s playing in the 
colony collapse of bees. Bees are particularly sensitive to neonicotinoids and exposure to it can 
result in immunosuppression, increased toxicity due to metabolites, and failure to thrive [4, 13, 
115]. Meanwhile, mammals are capable of rapid and efficient intestinal absorption of 
neonicotinoids. Studies have shown that IMI is biotransformed in mice into metabolites such as 
desnitro-imidacloprid (IMI-NH) that exhibit toxicity to mammals due to its ability to bind the 
α4β2 nAChR [4, 54]. Additionally, neonatal rat cerebellar neurons treated with neonicotinoids 
showed distinctive excitatory effects consistent with the activation of mammalian nAChRs 




neonicotinoids are capable of activating mammalian cells begs the question of what effect this 
could be having on the pathogen-specific immune response in mammals. Several studies 
conducted on mammals have shown neonicotinoids are capable of immunological effects. 
Treatment of rats with IMI increased the total leukocyte counts and total immunoglobulins, a 
decrease in phagocytic activity, chemokinesis, and chemotaxis [117]. The increase in total 
immunoglobulins was similar to what was observed in our titer of day 14 p.i. virus-specific 
antibodies. Other studies in which mice were treated with IMI resulted in suppressed cell-
mediated immune responses such as decreased percent of lymphocytes and total leukocyte 
counts, diminished macrophage function, reduction in the antibody response, and inhibition of T-
cell activity [118]. Our study had some noted similarities with what previous studies have shown 
in that we also saw a reduction in the T-cell’s (CD3+) ability to produce IFN-γ in PRRSV 
infected IMI treatment group at day 7 post infection. Overall, IMI had very little effect on the 
adaptive T-cell response but we did see a decrease in surface expression of MHC class II on 
monocytes (CD172a+SSClo) as a result of IMI treatment. 
 It is important to recognize that immune cells vary depending on the anatomical location 
and for the purposes of our experiments we focused on the peripheral blood cells. This is a 
drawback to the study due to the fact that neonicotinoids are readily absorbed through the 
intestines and it is possible that mucosal immunity would have been more effected by the IMI 
treatment. Additionally, PRRSV infects cells of the upper respiratory tract and on its own has 
immunosuppressive qualities. The use of a virus that infected the gastrointestinal tract, such as 
rotavirus, may have proved a better model with which to analyze the effects of IMI on immune 






In conclusion, this is the first study to characterize the effects of neonicotinoids on the 
generation of an immune response to a viral pathogen in pigs. We were able to identify that the 
expression of porcine α7nAChR is more consistent with the human receptor expression profile. 
Furthermore, we found that acute administration of IMI below the NOAEL had physiological 
effects on neonatal piglets that included hypothermia and reduced body weights that were 
especially evident in infected piglets. PRRSV infection caused an increase in the circulating 
levels of IL-10 at days 7 and 14 p.i. independent of treatment and IMI treated piglets had slightly 
higher levels present at day 14 p.i. Collectively our data indicate that IMI may adversely affect 
the generation of Type I immunity.  Additionally, an increase in IL-10 could be responsible for 
the upregulated production of the virus-specific antibodies in the IMI treated group. The 
antibodies assist in the dissemination and viremia of PRRSV indicating that exposure to IMI may 
cause PRRSV to become more virulent. At the very least our finding indicate that further 
investigation into the immunomodulatory properties of neonicotinods are warranted. Future 



















































Figure 1: The cholinergic anti-inflammatory pathway and putative action of neonicotinoids:  
Activation of the Vagal nerve depolarizes the splenic nerve causing norepinephrine (NE) 
release. NE signals β2AR+ T-cells to secrete acetylcholine. Acetylcholine-mediated activation 
of α7 nicotinic acetylcholine receptors (α7nAChR) on macrophages increases intracellular 
Ca+2, activates the JAK2/STAT3 pathway, inhibits NF-kB signaling and ablates 
proinflammatory responses.  α -bungarotoxin (α-BT) is a selective α7nAChR antagonist.  
Like nicotine, neonicotinoids excerpt their toxicity to insects in a manner that is dependent on 
the activation of α-BT sensitive nAChRs and thus may signal through α7nAChRs to cause 







Figure 2: A-D, The surface expression pattern of α7 nicotinic acetylcholine receptors 
(α7nAChR) on C57BL/6 mouse splenocyte cells was analyzed for their ability to bind 
fluorescently labeled α –bungarotoxin (α-BT) on T-cells (A; n= 3-5), macrophage (B; n= 3), 
B-cells (C; n= 3), and natural killer cells (D; n= 3). Flow cytometry gating strategy is 
provided for each cell type (Left), histograms show representative expression between 
unstained controls and α-BT stained cells (Middle), and graphs (Right) represent mean 
fluorescent intensity (MFI) of α-BT between unstained controls and α-BT stained cells. 







Figure 3: A-D, The expression pattern of the α7 nicotinic acetylcholine receptor (α7nAChR) 
on porcine peripheral blood mononuclear cells (PBMCs) was analyzed using fluorescently 
labeled α-bungarotoxin (α-BT) by flow cytometry. A-D, α-BT stain on T-cells (CD3+), helper 
T-cells (CD3+CD4+), and cytotoxic T-cells (CD3+CD8+) (A; n= 3), natural killer cells (CD3-
CD4-CD8+) (B; n= 3), monocytes (CD172a+SSClo) (C; n= 8), and granulocytes 
(CD172a+SSChi) (D; n= 8) is shown. Flow cytometry gating strategy is provided for each cell 
type (Left), histograms show representative expression between unstained controls and α-BT 
stained cells (Middle), and graphs (Right) represent mean fluorescent intensity (MFI) of α-BT 














Figure 4: A-B, The expression of the α7 nicotinic acetylcholine receptor (α7nAChR) on 
splenic T-cells (CD3+) (A) and monocytes (CD172a+) (B) was analyzed by flow cytometry 
after staining with, fluorescently labeled α-bungarotoxin (α-BT). Flow cytometry gating 
strategy is provided for each cell type (Left), histograms show representative expression 
between unstained and α-BT stained cells (Middle), and graphs represent mean fluorescent 
intensity (MFI) of α-BT between unstained controls and α-BT stained cells (Right). Results 







Figure 5: A-B, Characterization of porcine bone marrow derived dendritic cells (BMDC).  
Porcine bone marrow was cultured with recombinant porcine granulocyte-macrophage 
colony-stimulating factor (GM-CSF) and interleukin (IL)-14 (20 ng/mL) for 7-10 days.  Flow 
cytometry was used to determine percentage of CD172a+SLA DR+ dendritic cells.  The gating 
strategy for viable (Left), single (Middle), and dendritic cells (Right) is shown (A). Flow 
cytometry results indicate that >62% of the BMDC are CD172a+SLA DR+ dendritic cells.  
BMDC cultures were stained with α-bungarotoxin to determine expression of the α7 nicotinic 
acetylcholine receptor (α7nAChR) (B). Arrows indicate cells with varying levels of receptor 









Figure 6: A-C, Imidacloprid (IMI) increased surface α7 nicotinic acetylcholine receptor 
(α7nAChR) on porcine bone marrow derived dendritic cells (BMDC). Porcine BMDCs were 
plated at 5x105 cells/well and cultured for 24 hrs. in the presence of LPS (10 ng/ml) or IMI 
(500 μM) in serum free media supplemented with 0.5% bovine serum albumin (BSA). After 
stimulation cells were fixed then stained with Hoechst, fluorescently labeled α –bungarotoxin 
(α-BT), and antibody-specific for Iba-1(A). The mean fluorescent intensity (MFI) of α-BT 
was quantified for each treatment group using Image J (B). C, Cells counts were recorded for 
each treatment group using the Hoechst stained cells (C). Results are combined means ± S.E. 






Figure 7: A-C, Effect of infection and dietary imidacloprid (IMI) on weight, temperature, and 
feeding score. Feeding scores were recorded to assess willingness of the piglets to consume their 
first daily meal using a scoring system (1 = no attempt to consume the milk; 2 = attempted to 
consume the milk, but did not finish within 1 min; 3 = consumed all of the milk within 1 min). 
Piglets were inoculated with sterile saline or PRRSV 1x105 TCID50. One day prior to infection 
diets were supplemented with dimethyl sulfoxide vehicle or IMI (5 mg/kg body weight/day). 
Percent weight change (A), rectal temperatures (B), and feeding scores (C) are shown. Arrows 
indicate the day of infection. Infection caused intermittent fevers starting at day 2 post infection 
(p.i.) as well as a tendency for treatment with IMI to reduce fever caused by PRRSV infection 
(p≤0.0577). A main effect of IMI on body weight change was observed over the course of the 








Fig 8: A-B, Serum cytokines were measured on days 0, 3, 7, and 14 post infection (p.i.) by 
ELISA. Effect of treatment and infection on serum IL-10 (A) and TNF (B) levels are shown. 
Imidacloprid (IMI) increased circulating IL-10 (p≤0.01). Results are combined means ± S.E. 
from two independent experiments. ***p≤0.001, Day 0 n= 4-10, Day 3 n= 7-9, Day 7 n= 7-






Figure 9: A-F, Effect of infection and dietary imidacloprid (IMI) on peripheral blood leukocytes. 
Piglets were inoculated with sterile saline or PRRSV 1x105 TCID50. One day prior to infection diets 
were supplemented with dimethyl sulfoxide vehicle or IMI (5 mg/kg body weight/day). The effect of 
both infection and treatment on leukocyte populations were determined at days 0, 3, 7, and 14 post 
infection (p.i.). Flow cytometry gating strategy for monocyte (CD172a+SSClo) and granulocyte 
(CD172a+SSChi) cells for all groups at days 0, 3, 7, and 14 p.i. (A). Percentages of CD172a+SSClo 
monocytes (Left) and CD172a+SSChi granulocytes (Right) at days 0, 3, 7, and 14 p.i. (B). Flow 
cytometry gating strategy used to evaluate surface expression and percentage of CD80+SLA DR+ 
cells on CD172a+SSClo monocytes (Left) and CD172a+SSChi granulocytes (Right) (C). Percentages 
of CD80 on CD172a+SSClo monocytes (Left) and CD172a+SSChi granulocytes (Right) at days 0, 3, 7, 
and 14 p.i. (D). Percentages of SLA DR+ gated cells on CD172a+SSClo monocytes (Left) and 
CD172a+SSChi granulocytes (Right) at days 0, 3, 7, and 14 p.i. (E). Expression (Left) and mean 
fluorescent intensity (MFI; Right) of SLA DR on CD172a+SSClo monocytes at day 7 p.i. Results in 
B-F are combined means ± S.E. from two independent experiments. *p<.05, **p<.01, ***p<.001, 






Figure 10: A-E, Effect of infection and dietary imidacloprid (IMI) on peripheral blood T-
cells. Piglets were inoculated with sterile saline or PRRSV 1x105 TCID50. One day prior to 
infection diets were supplemented with dimethyl sulfoxide vehicle or IMI (5 mg/kg body 
weight/day). Peripheral blood mononuclear cells (PBMC) were analyzed at days 0, 3, 7, and 
14 post infection (p.i.) by flow cytometry. Gating strategy used to determine helper 
(CD3+CD4+) and cytotoxic (CD3+CD8+) T-cells and natural killer cells (CD3-CD4-CD8+) for 
all groups at days 0, 3, 7, and 14 p.i. (A). Percentages of CD3+ (Upper Left), CD3+CD4+CD8+ 
(Upper Right), CD3+CD4+ (Lower Left), and CD3+CD8+ (Lower Right) cells at days 0, 3, 7, 
and 14 p.i. (B). Percentages of CD3-CD4-CD8+ cells at days 0, 3, 7, and 14 p.i. (C). D-E, 
Following isolation PBMCs were stimulated with PMA and ionomycine in the presence of 
brefeldin-A for 4 hrs. then stained for surface markers and intracellular IFN-γ. Flow 
cytometry gating strategy for IFN-γ expression (Right) from T-cells (CD3+) (Left) for all 
groups at days 0, 3, 7, and 14 p.i. (D). Percentage of CD3+IFN-γ+ cell populations for all 
groups at days 3 and 7 p.i. (E). Results in B, C, & E are means ± S.E. from two independent 
experiments. *p<.05, **p<0.01, ***p<.001, Day 0 n= 5-9, Day 3 n= 2-5, Day 7 n= 7-10, Day 









Figure 11: A-C, Effect of dietary imidacloprid (IMI) and infection on virus-specific antibody 
levels. Porcine reproductive and respiratory syndrome virus (PRRSV) specific antibody levels 
were analyzed by ELISA at days 0, 3, 7, and 14 post infection (p.i.) (A). B-C, Dilution curve 
(B) and antibody titer (IC50; C) were generated following 2-fold serial dilution of serum 
obtained from infected piglets (day 14 p.i.). Top dilutions started at a 1:40 dilution and 
bottom dilution was 1:5120. Results in A-C are means ± S.E. from two independent 









Figure 12: A-C, Effect of imidacloprid (IMI) on viral RNA levels in lung, spleen, and 
plasma. Porcine tissues from infected piglets treated with the dimethyl sulfoxide vehicle or 
IMI (5 mg/kg body weight/day) were analyzed for the presence of PRRSV viral RNA by 
qRT-PCR using the formula 2-∆Ct. A&B, Effect of treatment on viral RNA expression in the 
lung (A) and spleen (B) at day 14 p.i. (n=5 pigs/group). Viral RNA expression in the plasma 
at days 7 and 14 post infection (p.i.) normalized to vehicle day 14 p.i. samples (C).  Results in 
A-C are means ± S.E. Results in A&B are from one experiment and results in C are combined 
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